Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Formic Acid | HCID 284 | — |
| Reactant | Hydroxylamine | HCID 787 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | HCID 68817351 | HCID 68817351 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 11855331 | HCID 11855331 | 11.6% |
Reaction Steps
To a solution of 4-[4-(2-methyl-quinolin-4-ylmethoxy)-benzenesulfonylamino]-piperidine-3-carboxylic acid (0.210 g, 0.459 mmol) and 1-hydroxybenzotriazole (HOBT, 0.186 g, 1.38 mmol) in DMF (10 mL) was added 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (0.264 g, 1.38 mmol) at 0° C. The reaction mixture stirred at 0° C. for 10 min, then warmed to 25° C. over 1.0 h. After re-cooling the reaction to 0° C., hydroxylamine (50% by wt in water solution, 0.5 mL, 4.6 mmol) was added. The reaction was allowed to warm to 25° C. over 19 h and then formic acid (0.151 g, 3.2 mmol) added. The reaction was stirred for 10 min at 25° C. and 40° C. for 30 min and then allowed to warm to 25° C. over 19 h. The DMF was removed in vacuo and the resulting oil was diluted in ethyl acetate (100 mL) and then washed with saturated aqueous sodium bicarbonate (3×30 mL) and brine (30 mL). The organic layer was dried over MgSO4, filtered and concentrated to obtain a crude solid (0.195 g). The crude product was purified by reverse phase HPLC (Gilson) on a Phenomex C-18 semi-prep column eluting with an acetonitrile:water gradient, to afford (3S,4R)-1 -formyl-4-[4-(2-methyl-quinolin-4-ylmethoxy)-benzenesulfonyl amino]-piperidine-3-carboxylic acid hydroxyamide as an amorphous white solid (0.025 g, 11.6%). MS: 499 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07595327B2 |
|---|
| Source dataset | uspto-grants-2009_09 |
|---|
| ORD ID | ord-26663a3b2f104f7b911d2993898c330d |
|---|
| Source note | uspto-grants-2009_09 |
|---|